Medcrypt

Medcrypt, founded in 2016, positions itself at the forefront of the intersection between healthcare and cybersecurity. Operating within the Health Care, Medical Devices, and Privacy and Security sectors, its innovative service model delivers slogan: "Proactive healthcare security — in a few lines of code."

The company offers a specialized data security as a service platform tailored for medical device OEMs. By safeguarding devices from medical imaging devices to pacemakers, Medcrypt prevents unauthorized interactions by ensuring devices operate exclusively on trusted instructions.

Headquartered in the United States, the company continues to attract investor interest, marked by a recent Series B investment on 24 January 2023, led by Dexcom Ventures. This injection of capital underscores confidence in Medcrypt's cutting-edge solutions and its potential to scale within the increasingly essential healthcare cybersecurity niche. Potential investors should recognize the robust demand and critical necessity for secure medical device operations in the healthcare sector.